Regulatory Framework for the Availability and Use of Animal Drugs in the United States

• Autores: Sanja Modric
• Localización: Veterinary Clinics of North America: Small Animal Practice: Small Animal Practice, ISSN-e 0195-5616, Vol. 43, Nº. 5, 2013 (Ejemplar dedicado a: Clinical Pharmacology and Therapeutics), págs. 1005-1012
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The goal of this article is to help practitioners understand the regulatory framework and basis for the approval of new animal drugs, the terminology and specific meaning of terms related to drug approval, and the marketing and use of veterinary drugs in companion animal practice. Understanding the differences between approved versus unapproved drugs and their use helps practitioners make the appropriate clinical decisions on their patients’ treatment. Only when buying approved animal drugs can clinicians be assured of product safety, effectiveness, and manufacturing to the strict standards for quality, purity, and potency, as well as truthful and complete labeling.